跳至主要内容
临床试验/IRCT201602019568N14
IRCT201602019568N14已完成未知

Surfactant administration via laryngeal mask airway (LMA) versus endotracheal tube in neonatal respiratory distress syndrome, a randomized controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 3 days(—)
性别
All

入选标准

  • born at less than 37 gestational weeks, weighed = 1200 grams, had a diagnosis of RDS within the first two hours of life, requiring continuous positive airway pressure (CPAP) support = 5cm H2O (with or without nasal intermittent positive pressure ventilation (PPV)), plus fraction of inspired oxygen (FiO2) between 30 - 60% to maintain blood oxygen saturation (SpO2) between 88 to 95%
  • Exclusion criteria: having a previous intubation, major malformations (craniofacial, cardiac or thoracic), mean arterial pressure (MAP) < 40 mmHg, Apgar score = 3 at 5 minutes, requiring FiO2 concentrations > 60%, pneumothorax prior to enrollment, apnea requiring assisted ventilation, diaphragmatic hernia, and parents’ refusal to give informed consent.

排除标准

  • 未提供

研究者

相似试验